|
EMA to Wait for More Experience Before Issuing Guidance on Companion Diagnostics
Known for its relatively relaxed regulation of companion diagnostics (CDx), guidance from the European Medicines Agency (EMA) is not expected until the agency gains more experience with these drug-device combinations, an expert says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives